MSH2 and colorectal carcinoma: This provides very strong evidence for co-segregation of the MSH2 c.2006G>T variant with CRC and EC based on the American Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) conversion method [22].